These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24973031)

  • 1. SMOKE IT! Promoting a change of opiate consumption pattern - from injecting to inhaling.
    Stöver HJ; Schäffer D
    Harm Reduct J; 2014 Jun; 11():18. PubMed ID: 24973031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'South Asian cocktail'--the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour.
    Ojha SP; Sigdel S; Meyer-Thompson HG; Oechsler H; Verthein U
    Harm Reduct J; 2014 May; 11():17. PubMed ID: 24886095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Taking away the chaos": a health needs assessment for people who inject drugs in public places in Glasgow, Scotland.
    Tweed EJ; Rodgers M; Priyadarshi S; Crighton E
    BMC Public Health; 2018 Jul; 18(1):829. PubMed ID: 29973179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peer-assisted injection as a harm reduction measure in a supervised consumption service: a qualitative study of client experiences.
    Pijl E; Oosterbroek T; Motz T; Mason E; Hamilton K
    Harm Reduct J; 2021 Jan; 18(1):5. PubMed ID: 33407575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringe exchanges: a public health response to problem drug use.
    Cox GM; Lawless MC; Cassin SP; Geoghegan TW
    Ir Med J; 2000; 93(5):143-6. PubMed ID: 11072923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
    Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
    Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Alcohol and Opioid Use Among Harm Reduction Clients.
    Winstanley EL; Stover AN; Feinberg J
    Addict Behav; 2020 Jan; 100():106027. PubMed ID: 31683186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency.
    Mars SG; Ondocsin J; Ciccarone D
    Harm Reduct J; 2018 May; 15(1):26. PubMed ID: 29769132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms.
    Toth EC; Tegner J; Lauridsen S; Kappel N
    Harm Reduct J; 2016 Oct; 13(1):27. PubMed ID: 27717366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.
    De P; Cox J; Boivin JF; Platt RW; Jolly AM
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):355-61. PubMed ID: 17721398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
    Takács IG; Demetrovics Z
    Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fix rooms could prevent infection in addicts.
    Fronzo C
    J Wound Care; 2017 Feb; 26(2):49. PubMed ID: 28182519
    [No Abstract]   [Full Text] [Related]  

  • 18. Coverage of harm reduction services and HIV infection: a multilevel analysis of five Chinese cities.
    Wu Q; Kamphuis C; Duo L; Luo J; Chen Y; Richardus JH
    Harm Reduct J; 2017 Feb; 14(1):10. PubMed ID: 28193236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk perception, changing social context, and norms prevent transition to regular injection among people who smoke heroin.
    Harris J; Shorter GW; Davidson G; Best P
    Drug Alcohol Depend; 2020 Mar; 208():107878. PubMed ID: 32014646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.